Sandoz Articles
Japan pharma appointments
15 May 1995
Sandoz pralodol
15 May 1995
UK DoH Starts Talks On Slimming Drugs
15 May 1995
First Approval For Roche's Mycophenolate Mofetil
15 May 1995
EUROPEAN STOCK COMMENT
8 May 1995
Prograf Linked To Cardiotoxicity?
17 April 1995
Sandoz Begins Trial Recruitment
17 April 1995
Teva Receives Approval
17 April 1995
Neoral Launched In UK
17 April 1995
FDA Panel Backs Cellcept For Acute Rejection
10 April 1995
Roussel-Uclaf Details Group Pipeline Plans
10 April 1995
European STOCK COMMENT
10 April 1995
Second European Launch For Prograf
10 April 1995
European Stock Comment
3 April 1995
Record Operating Performance At Ciba
3 April 1995
Cross-Species Transplants Nearing Reality?
3 April 1995
MMD Essential To Hoechst For Leading Pharma Role
3 April 1995
Sandoz Demergers To Focus On Pharmaceuticals
3 April 1995
Pharma/Biotech JVs And Mergers More Appealing
27 March 1995
Athena's Zanaflex Suffers Setback In USA
13 March 1995
Genetic Therapy Starts Phase I/II Trial
13 March 1995
Sandoz Receives Recommended Approval In USA
6 March 1995
Sandoz Research Relocation
27 February 1995
IFPMA Marketing Code Violation Publicized
20 February 1995
Clozapine Reduces Suicide In Schizophrenia
20 February 1995
Bayer Expands Production In Spain
13 February 1995
Sandoz Ups Stake In SyStemix Inc
6 February 1995
European Stock Comment
6 February 1995
New Chemical Entities Round-Up For 1994
6 February 1995
Wellcome Rejects Glaxo But Looks Elsewhere
6 February 1995
European STOCK COMMENT
30 January 1995
New Sino/Norwegian Pharma Company
30 January 1995
Sandoz' 1994 Sales Advance 11%
23 January 1995
FDA Letter On Clozapine Trials
23 January 1995
Europe: Where Next For Pharmaceuticals?
23 January 1995
Fast FDA Approvals Of User-Fee NMEs In 1994
16 January 1995
Renormax Approved In USA
9 January 1995
Sandoz Distribution In South Africa
2 January 1995
Oligopoly The Future For The Pharma Industry
2 January 1995
SangStat To Develop Generic Ciclosporin
19 December 1994
Astra Again Leading Performer, Says Insight
19 December 1994
Restructuring Message For French Drug Industry
19 December 1994
Leciva 1994 Expectations
12 December 1994
More US Companies Join Physicians' Online Service
5 December 1994
MDR: Misunderstood Drug Resistance?
5 December 1994
Calcitonin Nasal Spray Set For US Approval?
28 November 1994
World Immunology, Rheumatology Markets
28 November 1994
Sankyo's Profits Rise on Mevalotin Sales
28 November 1994
EUROPEAN STOCK COMMENT
14 November 1994
3% Increase In Sales For Sandoz
31 October 1994
HIV Therapy Options Examined
31 October 1994
Cost Effectiveness Of Sandimmun Neoral
31 October 1994
Successful Rx-To-OTC Drug Switching: NDMA
31 October 1994
Sandoz Pharma Launch In UK
24 October 1994
E & C Europe OTC Sales "Set To Treble By 2003"
24 October 1994
Clozapine Can Reduce Suicide Risk
24 October 1994
Drug Registration In Malaysia
24 October 1994
New Approaches To Treating Colds
24 October 1994
Sandoz Appointments
17 October 1994
Synthelabo Reorganizes Drug Research
17 October 1994
Glaxo Leads Pharma World League, Says DDT
17 October 1994
Synthelabo Reorganizes Drug Research
17 October 1994
European Stock Comment
10 October 1994
Neoral Is An Advance Over Sandimmun
10 October 1994
Sumatriptan Finally Launched In France
3 October 1994
EUROPE STOCK COMMENT
3 October 1994
European STOCK COMMENT
26 September 1994
1st-Half 1994 Health Care Deals Exceed $18 Billion
26 September 1994
Sandoz Completes Phase III Trials Of IL-3
26 September 1994
European Stock Comment
19 September 1994
Sandoz Hong Kong In Talks Over Parlodel
19 September 1994
European Stock Comment
12 September 1994
New Drug Developments In Transplant Medicine
12 September 1994
Improvement At Sandoz in 1994 1st Half
12 September 1994
Global Cardiovascular Market Growth Set To Slow
5 September 1994
Sandoz Stops Parlodel Anti-Lactation Sales
5 September 1994
German Rx Drug Sales Losing Out
5 September 1994
Employment Implications Of Mergers, Restructuring
5 September 1994
US NDMA Appointment
22 August 1994
Sandoz Loan Funding
22 August 1994
Sandoz Faces Parlodel Lawsuits In USA
22 August 1994
African Tender Awards; RCI Data
22 August 1994
Mixed Results From US Companies In 2nd Qtr
8 August 1994
Drug Executives Arrested In Venezuela
1 August 1994
Vertex Predicts Four Drugs In Trials By End-1994
25 July 1994
NEW OFFICE FOR SANDOZ
25 July 1994
DYNACIRC TO BE MARKETED BY SANDOZ
25 July 1994
European Stock Comment
25 July 1994
Protein Design: Rising Star In A Depressed sector?
25 July 1994
Re-Engineering Japanese R&D - Again
25 July 1994
SOLID VOLUME GROWTH HELPS SANDOZ' SALES
25 July 1994
Sandoz Launch In France
18 July 1994
Vigabatrin NDA Filed In The USA
18 July 1994
YVES DUNANT DIES
11 July 1994
CHANGES AT FARMINDUSTRIA
4 July 1994
CICLOSPORIN'S ROLE IN BOWEL INFLAMMATION
4 July 1994
WHAT FUTURE FOR STERLING HEALTH
4 July 1994
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Elan makes "transformational" acquisitions and a divestment
